Jung Ae Hong

Jung Ae Hong

Auto-generated profile, based on publicly available information

Jung Ae Hong

Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2020 in Artificial Organs
Verified
Journal Article
Closed access
AKAh-Ram Kim
Ah-Ram Kim
HPHanbit Park
Hanbit Park
SLSang Eun Lee
Sang Eun Lee
JAJung‐Min Ahn
Jung‐Min Ahn
DPDuk‐Woo Park
Duk‐Woo Park
MKMin‐Seok Kim
Min‐Seok Kim

1 January 2025 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JHJunho Hyun
Junho Hyun
SLSeung-Ah Lee
Seung-Ah Lee
SLSang Eun Lee
Sang Eun Lee
JHJung Ae Hong
Jung Ae Hong
MKMin-Seok Kim
Min-Seok Kim
JKJae-Joong Kim
Jae-Joong Kim
Hyun J, et al. Korean Circ J. 2025 Jul;55:e105. https://doi.org/10.4070/kcj.2025.0052

1 January 2023 in Korean Circulation Journal
Verified
Journal Article
Open access
PDF file
JHJung Ae Hong
Jung Ae Hong
AKAh-Ram Kim
Ah-Ram Kim
DPDayoung Pack
Dayoung Pack
JHJunho Hyun
Junho Hyun
SLSang Eun Lee
Sang Eun Lee
MKMin-Seok Kim
Min-Seok Kim
Korean Circulation Journal 대한심장학회지 순환기 Hong JA, et al. Korean Circ J. 2023 May;53:e41. https://doi.org/10.4070/kcj.2022.0348

16 March 2020 in International Journal of Heart Failure
Verified
Journal Article
Open access
JHJung Ae Hong
Jung Ae Hong
MKMin-Seok Kim
Min-Seok Kim
HPHanbit Park
Hanbit Park
SLSang Eun Lee
Sang Eun Lee
HYHan Young Yu
Han Young Yu
BOByung-Hee Oh
Byung-Hee Oh
Hong JA, et al. Int J Heart Fail. 2020 Mar;2:e8. https://doi.org/10.36628/ijhf.2019.0016

29 December 2021 in ESC Heart Failure
Verified
Journal Article
Open access
PDF file
JHJung Ae Hong
Jung Ae Hong
SLSang Eun Lee
Sang Eun Lee
SKSeon-Ok Kim
Seon-Ok Kim
MKMin-Seok Kim
Min-Seok Kim
HLHae-Young Lee
Hae-Young Lee
JKJae-Joong Kim
Jae-Joong Kim
Aims A waiting period of more than 3 months is recommended for patients before undergoing cardiac resynchronization therapy (CRT). However, due to an anticipated high mortality rate, early implementation of CRT might be beneficial for some patients. We aimed to evaluate the rate and the probability of left ventricular (LV) function improvement and their predictors in patients with heart failure (HF) with indications for CRT. Methods and results From March 2011 to February 2014, a total of 5625 hospitalized patients for acute HF were consecutively enrolled in 10 tertiary hospitals. Among them, we analysed 1792 patients (mean age 63.96 ± 15.42 years, female 63.1%) with left ventricular ejection fraction (LVEF) ≤ 35% at the baseline echocardiography and divided them into three groups: 144 with left bundle branch block (LBBB), 136 with wide QRS complexes without LBBB, and 1512 not having these findings (control). We compared and analysed these three groups for improvement of LV function at follow-up echocardiography. In patients who met CRT indications (patients with LBBB or wide QRS complexes without LBBB), logistic regression was performed to identify risk factors for no improvement of LV. No improvement of LV was defined as LVEF ≤ 35% at follow-up echocardiography or the composite adverse outcomes: death, heart transplantation, extracorporeal membrane oxygenation, or use of a ventricular assist device before follow-up echocardiography. A classification tree was established using the binary recursive partitioning method to predict the outcome of patients who met CRT indications. In a median follow-up of 11 months, LVEF improvement was observed in 24.3%, 15.4%, and 40.5% of patients with LBBB, wide QRS complexes without LBBB, and control, respectively. Patients meeting CRT indications had higher 3 month mortality rates than the control (24.6% vs. 17.7%, P = 0.002). Multivariable logistic regression analysis revealed that large LV end-systolic dimension [odds ratio (OR) 1.10, 95% confidence interval (CI) 1.05–1.15, P < 0.001], low LVEF (OR 0.92, 95% CI 0.87–0.98, P = 0.006), diabetes requiring insulin (OR 6.49, 95% CI 2.53–19.33, P < 0.001), and suboptimal medical therapy (OR 6.85, 95% CI 3.21–15.87, P < 0.001) were significant factors predictive of no improvement. A decision tree analysis was consistent with these results. Conclusions Patients with CRT indications had higher mortality during their follow-up compared with control. LV function improvement was rare in this population, especially when they had some risk factors. These results suggest that the uniform waiting period before CRT implantation could be reconsidered and individualized.

14 January 2021 in International Journal of Heart Failure
Verified
Journal Article
Open access
PDF file
JHJunho Hyun
Junho Hyun
SLSang Eun Lee
Sang Eun Lee
SLSeung-Ah Lee
Seung-Ah Lee
JHJung Ae Hong
Jung Ae Hong
MKMin-Seok Kim
Min-Seok Kim
JKJae-Joong Kim
Jae-Joong Kim
Hyun J, et al. Int J Heart Fail. 2021 Jan;3(1):51-58. https://doi.org/10.36628/ijhf.2020.0044